DPC Holdings: Analysts Cut Targets Ahead of November Earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
DPC Holdings PLC enters a pivotal two-week stretch with analyst targets falling sharply, index inclusion odds running high, and the stock down 31% over the past month despite a 10.7% bounce on Tuesday.
The analyst picture has turned meaningfully more cautious without outright flipping bearish. RBC Capital's Ken Herbert cut his target to $50 from $62 this week, maintaining an Outperform rating but acknowledging the stock's de-rating. Morgan Stanley's Kristine Liwag made a similar move on October 19, trimming to $43 from $59 while staying at Equal-Weight. Both moves come after the same two analysts raised targets to those levels following the strong August print, a full round-trip in under three months. The consensus mean target now stands at $55.20, nearly double the current price of $28.24. That gap is large enough to warrant a caveat: given how quickly targets have moved, the mean likely includes some older figures that have not yet been revised down. Barclays initiated coverage on October 9 with an Overweight and a $49 target, which at least confirms fresh bullish conviction at current levels. The Street broadly sees upside, but the direction of recent moves is uniformly lower.
The bull case rests on genuine operational momentum. Second-quarter revenues of $269 million rose 34% year-over-year. Adjusted EBITDA of $48 million came in at a 17.8% margin. Full-year guidance of $1.0 to $1.04 billion in revenue and $182 to $187 million in adjusted EBITDA implies continued growth. A $930 million backlog and four customer partnership agreements expected to contribute over $200 million in annual run-rate revenues by the second half of 2029 provide visibility that is rare in this part of the aerospace supply chain. The bears focus on margin fragility, specifically the exposure to Hafnium cost pass-through and the execution risk around scaling manufacturing. PE stands at 31.2x, down sharply over the past 30 days (the multiple has fallen by more than 17 points in a month as the stock has sold off), while EV/EBITDA has drifted higher to 25.1x as the EBITDA denominator is rising but the equity price is outpacing it to the downside.
Short positioning has grown but remains manageable rather than aggressive. Shares short have climbed roughly 7.5% over the past week to approximately 6.18 million, and are up about 10% over the past month, tracking the stock's decline. The ORTEX short score sits at 61.4, down from a recent high of 65.4 on October 14, suggesting the pace of short buildup is easing slightly even as the absolute level ticks up. Borrow availability has loosened considerably from the tightest point of the recent period. On October 14, availability fell to 33.8%, meaning roughly one share was available for every three already borrowed. It has since recovered to 113.7%, close to the levels seen in late September. The cost to borrow has also dropped back to 2.8%, from a brief spike to 8.4% on October 20. None of this points to a short-driven technical dislocation. The positioning looks more like measured scepticism than an aggressive squeeze setup.
The ownership picture adds an important structural overlay. Three large holders filed 13G disclosures after the company's listing: JFL GP Investors VI at 13.5%, Hill City Capital at 5.1%, and Searchlight at 6.0%. These are passive filings, so no activist agenda is on the record. That said, J.F. Lehman and Company holds 15.5% of shares and Searchlight holds 7% in total. With roughly 37% of the register tied to a small group of financial sponsors and specialty funds, the float dynamics are tighter than the market cap suggests. Insider buying at the IPO in June was substantial: director Charles Dirkson purchased over $36 million worth of shares at $33. The stock now trades well below that entry point, which is worth monitoring ahead of the next earnings print.
The index rebalance picture is also worth tracking. DPC was added to the Russell 1000 in September, an event that had already passed with $267 million of forced buying at the September 18 trade date. ORTEX now puts the probability of addition to the MSCI World IMI, MSCI EAFE IMI, MSCI Europe IMI and related MSCI small-cap indices at 70 to 71%, with an announcement date of November 11 and a trade date of November 30. That is the same day as the next earnings release, which lands on November 11. If the MSCI announcement lands on earnings day, the two catalysts coincide. The potential flow is $119 million across 3.5 days of average volume for each index, with the stock well above the $5.73 price that decides the inclusion, sitting at $28.24 against a market cap of $4.2 billion. Wikipedia attention has also picked up sharply, with a z-score of 4.6 against the company's own 90-day history, the highest retail attention reading in the dataset.
What to watch on November 11 is whether the revenue print holds to guidance and whether margin commentary addresses the Hafnium cost concern directly, given that the MSCI announcement falls on the same date and any earnings-driven move will interact with the mechanical index flows due at month-end.
Stocks in this article
See the live data behind this article on ORTEX.
Open DPC on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 21:09
- Data as of
- 28 Oct 2026, 21:08
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.